WallStreetZenWallStreetZen

NASDAQ: RPTX
Repare Therapeutics Inc Earnings & Revenue

RPTX past revenue growth

How has RPTX's revenue growth performed historically?
Company
-28.62%
Industry
81.78%
Market
19.94%
RPTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RPTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

RPTX earnings and revenue history

Current Revenue
$97.9M
Current Earnings
-$45.7M
Current Profit Margin
-46.7%

RPTX Return on Equity

Current Company
-19.8%
Current Industry
16.8%
Current Market
28.2%
RPTX's Return on Equity (-19.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RPTX announces earnings.

RPTX Return on Assets

Current Company
-16.5%
Current Industry
3.2%
RPTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RPTX Return on Capital Employed

Current Company
-24.97%
Current Industry
-42.4%
RPTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RPTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RPTX$97.86M-$53.84M-$45.69M+686.91%N/A
TELON/AN/AN/AN/AN/A
GALT$0.00-$41.25M-$44.78MN/AN/A
ZURA$0.00-$58.52M-$60.18MN/AN/A
ELEV$0.00-$39.39M-$39.35MN/AN/A

RPTX earnings dates

Next earnings date
Aug 7, 2024

Repare Therapeutics Earnings & Revenue FAQ

What were RPTX's earnings last quarter?

On Invalid Date, Repare Therapeutics (NASDAQ: RPTX) reported Q1 2024 earnings per share (EPS) of $0.31, up 137.35% year over year. Total Repare Therapeutics earnings for the quarter were $13.16 million. In the same quarter last year, Repare Therapeutics's earnings per share (EPS) was -$0.83.

If you're new to stock investing, here's how to buy Repare Therapeutics stock.

What was RPTX's earnings growth in the past year?

As of Q2 2024, Repare Therapeutics's earnings has grown year over year. Repare Therapeutics's earnings in the past year totalled -$45.69 million.

What is RPTX's earnings date?

Repare Therapeutics's earnings date is Invalid Date. Add RPTX to your watchlist to be reminded of RPTX's next earnings announcement.

What was RPTX's revenue last quarter?

On Invalid Date, Repare Therapeutics (NASDAQ: RPTX) reported Q1 2024 revenue of $52.40 million up 822.93% year over year. In the same quarter last year, Repare Therapeutics's revenue was $5.68 million.

What was RPTX's revenue growth in the past year?

As of Q2 2024, Repare Therapeutics's revenue has grown -28.62% year over year. This is 110.41 percentage points lower than the US Biotechnology industry revenue growth rate of 81.78%. Repare Therapeutics's revenue in the past year totalled $97.86 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.